AIRS · Airsculpt Technologies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.39M | - | $34.99M | $44.01M | $39.37M | - | $42.55M | $51.00M | $47.62M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $22.58M | - | $19.52M | $22.67M | $21.77M | - | $25.50M | $34.27M | $15.76M | - |
| Total Operating Expenses | $41.19M | - | $44.74M | $43.23M | $40.96M | - | $46.26M | $55.98M | $36.61M | - |
| D&A | $3.02M | - | $3.22M | $3.25M | $3.24M | - | $3.00M | $2.88M | $2.81M | - |
| Operating Income | ($1.80M) | - | ($9.75M) | $786.0K | ($1.59M) | - | ($3.72M) | ($4.98M) | $11.01M | - |
| Interest Expense | $1.20M | - | $1.41M | $1.56M | $1.53M | - | $1.59M | $1.51M | $1.53M | - |
| Income Tax | ($465.0K) | - | ($1.65M) | ($185.0K) | ($367.0K) | - | $733.0K | ($3.29M) | $3.45M | - |
| Net Income | ($2.40M) | - | ($9.51M) | ($591.0K) | ($2.85M) | - | ($6.04M) | ($3.21M) | $6.03M | - |
| EPS - Basic | ($0.03) | - | ($0.15) | ($0.01) | ($0.05) | - | ($0.10) | ($0.06) | $0.10 | - |
| EPS - Diluted | ($0.03) | - | ($0.15) | ($0.01) | ($0.05) | - | ($0.10) | ($0.06) | $0.10 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.69M | $8.45M | $5.41M | $8.19M | $5.55M | $8.23M | $5.97M | $9.87M | $10.97M | $10.26M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $7.46M | $5.37M | $4.46M | $3.34M | $4.14M | $6.26M | $6.79M | $4.56M | $4.32M | $3.92M |
| Current Assets | $24.33M | $15.46M | $12.22M | $16.41M | $15.30M | $17.12M | $12.89M | $21.69M | $14.99M | $15.96M |
| Total Assets | $192.00M | $187.30M | $185.92M | $198.37M | $203.26M | $210.00M | $208.25M | $210.11M | $202.71M | $204.02M |
| Current Liabilities | $32.48M | $27.90M | $24.16M | $25.83M | $26.79M | $28.61M | $25.35M | $25.12M | $21.77M | $20.32M |
| Long-term Debt | $39.36M | $50.59M | $51.91M | $53.19M | $64.26M | $65.46M | $66.42M | $67.54M | $68.52M | $69.50M |
| Total Liabilities | $91.74M | $99.59M | $103.81M | $107.21M | $125.93M | $130.71M | $125.71M | $125.10M | $119.21M | $120.03M |
| Stockholders' Equity | $100.26M | $87.71M | $82.11M | $91.16M | $77.33M | $79.29M | $82.54M | $85.01M | $83.50M | $83.99M |
| Retained Earnings | ($42.97M) | ($40.57M) | ($40.75M) | ($31.24M) | ($30.65M) | ($27.80M) | ($22.77M) | ($16.73M) | ($13.52M) | ($19.55M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.27M | - | - | - | $868.0K | - | - | - | $3.37M | - |
| Investing Cash Flow | ($51.0K) | - | - | - | ($1.90M) | - | - | - | ($1.56M) | - |
| Financing Cash Flow | $3.02M | - | - | - | ($1.65M) | - | - | - | ($1.10M) | - |
| CapEx | $51.0K | - | - | - | $1.90M | - | - | - | $1.56M | - |
| Free Cash Flow | $5.22M | - | - | - | ($1.03M) | - | - | - | $1.80M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -4.6% | - | -27.9% | 1.8% | -4.0% | - | -8.7% | -9.8% | 23.1% | - |
| EBITDA margin | 3.1% | - | -18.7% | 9.2% | 4.2% | - | -1.7% | -4.1% | 29.0% | - |
| Net margin | -6.1% | - | -27.2% | -1.3% | -7.2% | - | -14.2% | -6.3% | 12.7% | - |
| Free cash flow margin | 13.3% | - | - | - | -2.6% | - | - | - | 3.8% | - |
| FCF / Net income | -2.18 | - | - | - | 0.36 | - | - | - | 0.30 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 57.3% | - | 55.8% | 51.5% | 55.3% | - | 59.9% | 67.2% | 33.1% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | 36.4% | - |
| Return on assets | -1.2% | - | -5.1% | -0.3% | -1.4% | - | -2.9% | -1.5% | 3.0% | - |
| Return on equity | -2.4% | - | -11.6% | -0.6% | -3.7% | - | -7.3% | -3.8% | 7.2% | - |
| Return on invested capital | -1.0% | - | -5.7% | 0.4% | -0.9% | - | -2.0% | -2.6% | 4.6% | - |
| Liquidity | ||||||||||
| Current ratio | 0.75 | 0.55 | 0.51 | 0.64 | 0.57 | 0.60 | 0.51 | 0.86 | 0.69 | 0.79 |
| Quick ratio | 0.75 | 0.55 | 0.51 | 0.64 | 0.57 | 0.60 | 0.51 | 0.86 | 0.69 | 0.79 |
| Cash ratio | 0.51 | 0.30 | 0.22 | 0.32 | 0.21 | 0.29 | 0.24 | 0.39 | 0.50 | 0.51 |
| Leverage | ||||||||||
| Debt / Equity | 0.39 | 0.58 | 0.63 | 0.58 | 0.83 | 0.83 | 0.80 | 0.79 | 0.82 | 0.83 |
| Debt / Assets | 0.20 | 0.27 | 0.28 | 0.27 | 0.32 | 0.31 | 0.32 | 0.32 | 0.34 | 0.34 |
| Debt / EBITDA | 32.29 | - | - | 13.19 | 38.88 | - | - | - | 4.96 | - |
| Interest coverage | -1.5x | - | -6.9x | 0.5x | -1.0x | - | -2.3x | -3.3x | 7.2x | - |
| Equity multiplier | 1.91 | 2.14 | 2.26 | 2.18 | 2.63 | 2.65 | 2.52 | 2.47 | 2.43 | 2.43 |
| Liabilities / Assets | 0.48 | 0.53 | 0.56 | 0.54 | 0.62 | 0.62 | 0.60 | 0.60 | 0.59 | 0.59 |
| Efficiency | ||||||||||
| Asset turnover | 0.21 | - | 0.19 | 0.22 | 0.19 | - | 0.20 | 0.24 | 0.23 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | 61.4x | - |
| P / B | 2.0x | - | 6.1x | 3.2x | 1.8x | - | 3.5x | 2.7x | 4.3x | - |
| P / S | 5.0x | - | 14.3x | 6.5x | 3.5x | - | 6.9x | 4.5x | 7.5x | - |
| EV / EBITDA | 179.9x | - | - | 82.5x | 118.2x | - | - | - | 30.1x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.0% | - | -17.8% | -13.7% | -17.3% | - | -9.1% | -8.4% | 3.9% | - |
| Revenue CAGR (3y) | -4.9% | - | 0.3% | -3.9% | -0.1% | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -13.4% | - | -162.4% | - | - | - | - | - | 525.0% | - |
| Net income growth (YoY) | 15.8% | - | -57.5% | 81.6% | - | - | -262.3% | - | - | - |
| EPS growth (YoY) | 40.0% | - | -50.0% | 83.3% | - | - | -233.3% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | -25.0% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 29.6% | 10.6% | -0.5% | 7.2% | -7.4% | -5.6% | -2.0% | 4.3% | 11.0% | 18.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$151.82M totalReportable Segment$151.82M · 100.0%
Geographic
$4.60M totalNon Us$4.60M · 100.0%
Peer comparison
Same SIC group: Services-Offices & Clinics of Doctors of Medicine
Comparing Airsculpt Technologies against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Aug 25, 2022 | $0.4100 |